Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Asia Pacific Prostate Cancer Conference /
mCRPC management in Taiwan - expert interview

1st - 2nd Mar 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.03.14
Views: 2933
Rating:

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang

Speaking to ecancer from the Academy for Cancer Education (ACE) 3rd Asia Pacific Prostate Cancer Conference (APPCC) in Shanghai, Prof Paul de Souza from the University of Western Sydney, Australia, interviews Dr Wayne Yen-Hwa Chang from the Taipei Veterans General Hospital in Taiwan. 

Dr Chang begins by defining clinical progression in metastatic castration-resistant prostate cancer (mCRPC), noting how much weight he places on PSA progression within this definition. He emphasises the importance of early identification of progression, and of early management. He goes on to outline the role of biomarkers in assessing disease progression and guiding treatment choice.

Dr Chang notes how mCRPC is managed in Taiwan with the drugs available, and emphasises the importance of enrolling patients into clinical trials. Dr Chang then comments on how he thinks treatment will change in the coming years in Taiwan, and the cost-effectiveness of therapy.

This video is sponsored by an educational grant from Janssen Asia Pacific, pharmaceutical companies of Johnson & Johnson

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation